@misc{indiciae2ec3757532ee,
  title = {Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors},
  author = {Tiedje, V. and Greenberg, J. and Qin, T. and Im, S.-Y. and Krishnamoorthy, G. P. and Boucai, L. and Xu, B. and French, J. D. and Sherman, E. J. and Ho, A. L. and De Stanchina, E. and Socci, N. D. and Jin, J. and Ghossein, R. and Knauf, J. A. and Koche, R. P. and Fagin, J. A.},
  year = {2025},
  doi = {10.1101/2025.01.27.635086},
  url = {https://www.biorxiv.org/content/10.1101/2025.01.27.635086v1},
  note = {Source identifier: 10.1101/2025.01.27.635086}
}